162 related articles for article (PubMed ID: 10936857)
1. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.
Kowal-Vern A; Mazzella FM; Cotelingam JD; Shrit MA; Rector JT; Schumacher HR
Am J Hematol; 2000 Sep; 65(1):5-13. PubMed ID: 10936857
[TBL] [Abstract][Full Text] [Related]
2. Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis.
Mazzella FM; Kowal-Vern A; Shrit MA; Wibowo AL; Rector JT; Cotelingam JD; Collier J; Mikhael A; Cualing H; Schumacher HR
Am J Clin Pathol; 1998 Nov; 110(5):590-8. PubMed ID: 9802343
[TBL] [Abstract][Full Text] [Related]
3. Sub classification and clinico-hematological correlation of 40 cases of acute erythroleukemia - can proerythroblast/myeloblast and proerythroblast/total erythroid cell ratios help subclassify?
Srinivas U; Kumar R; Pati H; Saxena R; Tyagi S
Hematology; 2007 Oct; 12(5):381-5. PubMed ID: 17852448
[TBL] [Abstract][Full Text] [Related]
4. Effects of multidrug resistance gene expression in acute erythroleukemia.
Mazzella FM; Kowal-Vern A; Shrit MA; Rector JT; Cotelingam JD; Schumacher HR
Mod Pathol; 2000 Apr; 13(4):407-13. PubMed ID: 10786807
[TBL] [Abstract][Full Text] [Related]
5. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of proerythroblasts in acute erythroleukemia.
Kowal-Vern A; Cotelingam J; Schumacher HR
Am J Clin Pathol; 1992 Jul; 98(1):34-40. PubMed ID: 1615923
[TBL] [Abstract][Full Text] [Related]
7. Mixed colony formation composed of erythroblasts and myeloblasts by leukemic blast progenitors in patients with erythroleukemia.
Nara N; Tanikawa S; Shiina S
Exp Hematol; 1993 Jan; 21(1):98-102. PubMed ID: 8417964
[TBL] [Abstract][Full Text] [Related]
8. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
[TBL] [Abstract][Full Text] [Related]
9. Acute erythroleukemia--M6B.
Mohanty R; Dash B; Chawla SC; Paul HS
Indian J Pathol Microbiol; 2001 Oct; 44(4):461-2. PubMed ID: 12035366
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients.
Mazzella FM; Smith D; Horn P; Cotelingam JD; Rector JT; Shrit MA; Pesce A; Schumacher HR
Am J Hematol; 2006 Jul; 81(7):484-91. PubMed ID: 16755568
[TBL] [Abstract][Full Text] [Related]
11. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE
Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273
[TBL] [Abstract][Full Text] [Related]
12. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
Goldberg SL; Noel P; Klumpp TR; Dewald GW
Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
[TBL] [Abstract][Full Text] [Related]
13. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Ardanaz MT; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
Mod Pathol; 2016 Dec; 29(12):1541-1551. PubMed ID: 27562492
[TBL] [Abstract][Full Text] [Related]
14. Erythroleukemia-historical perspectives and recent advances in diagnosis and management.
Boddu P; Benton CB; Wang W; Borthakur G; Khoury JD; Pemmaraju N
Blood Rev; 2018 Mar; 32(2):96-105. PubMed ID: 28965757
[TBL] [Abstract][Full Text] [Related]
15. An acute myeloid leukemia M6b blast crisis with giant proerythroblasts in chronic myeloid leukemia.
Sharma P; Dhingra KK; Roy S; Singh T
J Pediatr Hematol Oncol; 2009 Mar; 31(3):220-1. PubMed ID: 19262253
[TBL] [Abstract][Full Text] [Related]
16. The acute erythroleukemias.
Mazzella FM; Alvares C; Kowal-Vern A; Schumacher HR
Clin Lab Med; 2000 Mar; 20(1):119-37. PubMed ID: 10702900
[TBL] [Abstract][Full Text] [Related]
17. Hemopoietic precursor cells in erythroleukemia.
Suda T; Miura Y; Ozawa K; Mizoguchi H; Takaku F
Stem Cells (1981); 1982; 1(4-5):224-32. PubMed ID: 6959295
[TBL] [Abstract][Full Text] [Related]
18. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
[TBL] [Abstract][Full Text] [Related]
19. Acute erythroid leukemia.
Zuo Z; Polski JM; Kasyan A; Medeiros LJ
Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
[TBL] [Abstract][Full Text] [Related]
20. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]